medigraphic.com

2003, Number s1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2003; 41 (s1)

Clinical Guideline for Diagnosis and Treatment of New Cases of Lung Tuberculosis

Trejo y PJA, Díaz RRD, Moreno MG, Palacios JNM, Soriano AL, Carrasco RJR

Language: Spanish
References: 16
Page: 83-90
PDF size: 288.53 Kb.


ABSTRACT

Tuberculosis continues to be a public health problem throughout the world and as well as inMexico. Tuberculosis of the lung is the main source of transmission. Two major aspects need to be addressed to improve efficacy, to carry out detection in social networks because in 20 to 30 % of new cases this is not done, and to pursue compliance with the full-treatment scheme. The efficacy rate was 65 % in the year 2002 and this was due to noncompliance or abandonment of treatment. Evidence-based clinical guidelines were developed to provide recommendations to primary-care providers with regard to diagnosis, treatment, and follow-up. The guidelines take into account risk factors for lack of compliance or abandonment of treatment. Additionally, criteria for referral to other levels of care and for identification of adverse drug reactions were included.


REFERENCES

  1. Dirección General de Epidemiología. Subdirección de Investigación y Evaluación. Evaluación técnica del programa de acción. Tuberculosis. México: Secretaría de Salud; 2002.

  2. Small P, Fujiwara P. Management of tuberculosis in the United States. N Engl J Med 2001;345:189-200.

  3. Norma oficial mexicana NOM-006-SSA-1993 para la prevención y control de la tuberculosis en la atención primaria. Diario Oficial de la Federación 29 de noviembre 1994.

  4. Sistema Único de Información. Programa “México libre de tuberculosis. Pautas de tratamiento y retratamiento de tuberculosis”. Sistema Nacional de Vigilancia Epidemiológica. México: Secretaría de Salud; 2002;19(26).

  5. Gatner E, Burkhardt. Correlation of the results of X-Ray and sputum culture in tuberculosis prevalence surveys. Tubercle 1980;61:27-31.

  6. Correa A. Tuberculosis. Unique aspects of tuberculosis in the pediatric population. Clin Chest Med 1997;18:89-98.

  7. Horsburgh R, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000;31:633-639.

  8. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Infectious Diseases Group 2002;(Issue 1).

  9. Gelband H. Regimens of less than six months for treating tuberculosis. Cochrane Infectious Diseases Group 2002;(Issue 1).

  10. Mwandumba HC. Fully intermittent dosing with drugs for treating tuberculosis in adults. Cochrane Infectious Diseases Group 2002;(Issue 1).

  11. Van Scoy R, Wilkowske C. Antimycobacterial therapy. Mayo Clin Proc 1999;74:1038-1048.

  12. Cheng T, Ottolini M, Baumhaft K, Brasseux C, Wolf M, Scheidt P. Strategies to increase adherence with tuberculosis test reading in a high-risk population. Pediatrics 1997;100:210-213.

  13. Sumartojo E. When tuberculosis treatment fail. A social behavioral account of patient adherence. Am Rev Respir Dis 1993;147:1311-1323.

  14. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395.

  15. Bradford W, Daley C. Emerging infectious diseases. Multiple drug-resistant tuberculosis. Infect Dis Clin North Am 1998;12:157-172.

  16. Parsons L, Driscoll J, Taber H, Salfinger M. Antimicrobial resistence. Drug resistance in tuberculosis. Infec Dis Clin North Am 1997;11:905-928




2020     |     www.medigraphic.com